BATM Advanced Communications Limited’s (LON:BVC) delivery of a new Celitron instrument underlines how quickly the group is developing in all areas, says house broker Shore Capital.
The main market-listed group announced this morning that its Celitron arm had sold the machine to a Belgian customer that will use it to produce high-quality insect protein powder and oil.
Celitron is already using its integrated steriliser and shredder (ISS) technology on harmful agricultural and medical waste to render them benign.
This latest bit of kit recovers solid protein and oils from insects such as worms and flies that feed on waste.
The result is an insect protein powder that can be used as a substitute for fishmeal and oils in aquaculture feed.
Celitron had already picked up orders worth US$8.3mln this year, but this is a new market application for its technology.
BATM shares have enjoyed a good run this year on the back of its success in COVID-19-related diagnostic solutions while in the Networking & Cyber division, progress has also been strong.
The recent contract with a Tier 1 network provider for its NFVTime solution while a COVID-19 test solution for a significant global private laboratory group headquartered in Italy providing COVID-19 testing throughout Europe, primarily for large businesses such as airports.
The successful launch of its NFVTime solution heralds a material growth opportunity, in the view of Shore Cap, while Celitron look set to grow into 2021.
“BATM is addressing large market opportunities demanding technology-based solutions,” added the broker, which it said it sees further upgrades ahead.
Shares rose 3.5% to 88.8p.